ELDA analysis revealed that the cancer cell-initiating frequency of double-positive (1/316) was four times higher in comparison to the one of L1CAM+/CD133− (1/1245), three times higher than double-negative (1/1056) and six times higher than IGROV1 wild-type cells (1/1881). Here, L1CAM is linked to cancer.